Radiopharmaceuticals Gain Traction for Cancer Theranostics Potential
After decades of neglect from big pharma, radiopharmaceuticals are generating major oncology deals globally. This…
06/11/2020 - 6 minutes
Novartis
Update: Novartis’ Gene Therapy Zolgensma Gets Nod from EU
Update (19/05/2020): The gene therapy Zolgensma, developed by the big pharma Novartis and approved in…
19/05/2020 - 5 minutes
Update: FDA Imposes No Penalties for Novartis Data Manipulation Scandal
Update (02/04/2020): The FDA has concluded an investigation into a data manipulation scandal surrounding the…
02/04/2020 - 3 minutes
Novartis Enters RNA Therapeutics with Medicines Company Merger
Novartis is to acquire The Medicines Company and its late-stage RNA interference drug designed to…
25/11/2019 - 3 minutes
Needle-Free Diabetes Care: 8 Devices that Painlessly Measure Blood Glucose
Will the daily routine of finger pricking to monitor blood glucose levels finally come to…
20/11/2019 - 5 minutes
European Project Launches to Tailor Autoimmune Disease Treatments
Public and private organizations across Europe will pool their resources in an €80M project to…
31/10/2019 - 2 minutes
Trial Testing Spinal Application of Zolgensma Put on Hold by FDA
The FDA has placed a partial hold on clinical trials testing a new application method…
30/10/2019 - 2 minutes
MorphoSys and Galapagos’ Eczema Drug Abandoned at Phase II
Development of MorphoSys, Galapagos, and Novartis’ first-in-class antibody drug has been discontinued during a phase…
29/10/2019 - 2 minutes
A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
10/09/2019 - 9 minutes
Top Cardiology Biotech News from the ESC Conference 2019
Many cardiology companies and academics gathered in Paris earlier this week to showcase their latest…
05/09/2019 - 4 minutes
Seventure Continues Microbiome Investment Success with Second Fund
After the success of the world’s first fund dedicated to companies in nutrition, digital health,…
05/03/2019 - 3 minutes
Swiss-Italian Biotech Bags Antibody Deals with Three Big Pharma
The Swiss-Italian company Philogen has announced three different partnerships with Novartis, Celgene, and Janssen to…
25/01/2019 - 2 minutes
